Which is more effective at lowering LDL cholesterol, pravastatin or rosuvastatin?
Rosuvastatin is generally the stronger LDL-lowering option at typical doses. Clinical practice comparisons usually place rosuvastatin ahead of pravastatin in potency, meaning patients often need less rosuvastatin (by milligram) to reach similar LDL reductions.
How do they compare for lowering triglycerides and raising HDL?
For triglycerides and HDL, both drugs can help, but rosuvastatin tends to produce a somewhat greater overall lipid change in many head-to-head or comparative analyses used in practice. The size of the effect varies by baseline cholesterol pattern (for example, whether triglycerides are high or low to start).
What about dosing—can you take a lower dose with rosuvastatin?
In general, rosuvastatin is the more potent statin, so the starting and usual effective doses can be lower numerically than pravastatin. The exact best dose depends on your LDL level, cardiovascular risk, and how you tolerated previous statins.
Side effects and muscle risk: which is more likely to cause problems?
Both pravastatin and rosuvastatin can cause side effects, including muscle aches and, rarely, more serious muscle injury. The likelihood of muscle-related side effects is influenced more by factors like dose, age, kidney/liver function, drug interactions, and personal history than by the statin brand alone.
If you have had statin-associated muscle symptoms before, clinicians often switch statins (or adjust dose) rather than assuming one is always safer.
Drug interactions: is one easier with other medicines?
This is a key reason clinicians sometimes pick pravastatin over more interaction-prone options. Pravastatin is commonly considered to have fewer clinically significant interactions because it is handled differently by drug-metabolizing pathways than some other statins. Rosuvastatin also has a relatively manageable interaction profile, but the overall safety depends on the specific co-medications.
Kidney and liver considerations
Rosuvastatin dosing may need adjustment in people with reduced kidney function. Pravastatin is also used in patients with kidney disease, but the dosing approach can differ. In people with liver disease, both require caution and monitoring, and clinicians typically check liver enzymes before starting and if symptoms occur.
If you already take a statin, how do doctors decide between them?
Common decision points include:
- your current LDL response and whether you need more lowering
- prior side effects (especially muscle symptoms)
- other medications you take (interaction risk)
- kidney function and dose-adjustment needs
- whether the goal is moderate- versus high-intensity LDL lowering
Bottom line
If your goal is the strongest LDL lowering with a statin, rosuvastatin is usually the more potent choice. If you’re trying to minimize drug-interaction complexity or you had intolerance with another statin, pravastatin is often a reasonable alternative. The “best” pick depends on your dose target and your risk factors for side effects.
If you tell me your age, the most recent LDL (and whether triglycerides are high), your other medications, and any prior statin side effects, I can help you think through which direction (pravastatin vs rosuvastatin) usually fits best.